Economic Implications of Treatment-Resistant Depression Among Employees
Year of publication: |
2004
|
---|---|
Authors: | Greenberg, Paul ; Corey-Lisle, Patricia K. ; Birnbaum, Howard ; Marynchenko, Maryna ; Claxton, Ami |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 22.2004, 6, p. 363-373
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Cost-of-illness | Depression |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
The Economic Impact of Neuropsychiatric Symptoms in Alzheimer's Disease: Can Drugs Ease the Burden?
Murman, Daniel L., (2005)
-
Cost Effectiveness of Fluvoxamine in the Treatment of Recurrent Depression in France
Nuijten, Mark, (1998)
-
Depression in the Workplace: Epidemiology, Economics and Effects of Treatment
Russell, James M., (1998)
- More ...
-
Generic competition in the US pharmaceutical industry
Saha, Atanu, (2006)
-
Generic Competition in the US Pharmaceutical Industry
Saha, Atanu, (2006)
-
Generic Competition in the US Pharmaceutical Industry
Saha, Atanu, (2006)
- More ...